MX2024011963A - Vectores de virus adenoasociados para la entrega de acido nucleico a las celulas retinianas - Google Patents
Vectores de virus adenoasociados para la entrega de acido nucleico a las celulas retinianasInfo
- Publication number
- MX2024011963A MX2024011963A MX2024011963A MX2024011963A MX2024011963A MX 2024011963 A MX2024011963 A MX 2024011963A MX 2024011963 A MX2024011963 A MX 2024011963A MX 2024011963 A MX2024011963 A MX 2024011963A MX 2024011963 A MX2024011963 A MX 2024011963A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- vectors
- adeno
- delivery
- associated virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14145—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325551P | 2022-03-30 | 2022-03-30 | |
| US202263325555P | 2022-03-30 | 2022-03-30 | |
| US202263325562P | 2022-03-30 | 2022-03-30 | |
| US202263325550P | 2022-03-30 | 2022-03-30 | |
| US202263325559P | 2022-03-30 | 2022-03-30 | |
| US202263325541P | 2022-03-30 | 2022-03-30 | |
| US202263325548P | 2022-03-30 | 2022-03-30 | |
| US202263325540P | 2022-03-30 | 2022-03-30 | |
| US202263325553P | 2022-03-30 | 2022-03-30 | |
| US202263325544P | 2022-03-30 | 2022-03-30 | |
| US202263325543P | 2022-03-30 | 2022-03-30 | |
| US202263325558P | 2022-03-30 | 2022-03-30 | |
| US202263325542P | 2022-03-30 | 2022-03-30 | |
| PCT/US2023/016871 WO2023192463A2 (en) | 2022-03-30 | 2023-03-30 | Adeno-associated virus vectors for nucleic acid delivery to retinal cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024011963A true MX2024011963A (es) | 2024-11-08 |
Family
ID=88203541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024011963A MX2024011963A (es) | 2022-03-30 | 2024-09-27 | Vectores de virus adenoasociados para la entrega de acido nucleico a las celulas retinianas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250327092A1 (enExample) |
| EP (1) | EP4499848A4 (enExample) |
| JP (1) | JP2025510975A (enExample) |
| KR (1) | KR20250006360A (enExample) |
| CN (1) | CN119213136A (enExample) |
| AU (1) | AU2023243048A1 (enExample) |
| CA (1) | CA3255255A1 (enExample) |
| IL (1) | IL316014A (enExample) |
| MX (1) | MX2024011963A (enExample) |
| TW (1) | TW202405180A (enExample) |
| WO (1) | WO2023192463A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122319247A (zh) * | 2023-09-27 | 2026-06-30 | 匹兹堡大学联邦系统高等教育 | 将核酸递送至视网膜细胞、跨视网膜区递送核酸或将核酸递送至视网膜神经节细胞和/或视网膜色素上皮细胞的腺相关病毒载体 |
| WO2026039585A2 (en) * | 2024-08-16 | 2026-02-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Adeno-associated virus vectors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007084773A2 (en) * | 2006-01-20 | 2007-07-26 | University Of North Carolina At Chapel Hill | Enhanced production of infectious parvovirus vectors in insect cells |
| DK3693025T3 (da) * | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| US11136557B2 (en) * | 2013-05-31 | 2021-10-05 | The Regents Of The University Of California | Adeno-associated virus variants and methods of use thereof |
| CN110612353A (zh) * | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| KR20250023600A (ko) * | 2017-06-30 | 2025-02-18 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법 |
| US12421525B2 (en) * | 2018-02-28 | 2025-09-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Conjugates comprising AAVs and CAS9 polypeptides |
| US20220348613A1 (en) * | 2019-08-28 | 2022-11-03 | University of Pittsburgh - of the Commonwealath System of Higher Ecucation | Adeno-associated viruses and methods and materials for making and using adeno-associated viruses |
| US20220313722A1 (en) * | 2019-09-09 | 2022-10-06 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb |
-
2023
- 2023-03-30 US US18/851,534 patent/US20250327092A1/en active Pending
- 2023-03-30 JP JP2024557528A patent/JP2025510975A/ja active Pending
- 2023-03-30 CN CN202380040951.9A patent/CN119213136A/zh active Pending
- 2023-03-30 EP EP23781800.0A patent/EP4499848A4/en active Pending
- 2023-03-30 CA CA3255255A patent/CA3255255A1/en active Pending
- 2023-03-30 TW TW112112171A patent/TW202405180A/zh unknown
- 2023-03-30 AU AU2023243048A patent/AU2023243048A1/en active Pending
- 2023-03-30 IL IL316014A patent/IL316014A/en unknown
- 2023-03-30 WO PCT/US2023/016871 patent/WO2023192463A2/en not_active Ceased
- 2023-03-30 KR KR1020247036295A patent/KR20250006360A/ko active Pending
-
2024
- 2024-09-27 MX MX2024011963A patent/MX2024011963A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN119213136A (zh) | 2024-12-27 |
| KR20250006360A (ko) | 2025-01-10 |
| EP4499848A2 (en) | 2025-02-05 |
| TW202405180A (zh) | 2024-02-01 |
| AU2023243048A1 (en) | 2024-10-03 |
| US20250327092A1 (en) | 2025-10-23 |
| IL316014A (en) | 2024-11-01 |
| CA3255255A1 (en) | 2023-10-05 |
| JP2025510975A (ja) | 2025-04-15 |
| EP4499848A4 (en) | 2026-03-25 |
| WO2023192463A3 (en) | 2023-12-21 |
| WO2023192463A2 (en) | 2023-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019003561A1 (es) | Agentes potenciadores para la transfección celular mejorada y/o la producción del vector raav. | |
| PE20191261A1 (es) | Composiciones utiles para el tratamiento de atrofia muscular espinal | |
| WO2019169004A8 (en) | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor | |
| BR112021018776A2 (pt) | Vetores de vírus adenoassociado recombinante | |
| WO2021198706A3 (en) | Coronavirus vaccines | |
| MX2024011862A (es) | Vectores de virus adenoasociados para la entrega de acido nucleico a traves de las regiones retinianas | |
| AR126625A1 (es) | Vacunas de arn | |
| PE20221254A1 (es) | Proteina vp1 modificada aislada de la capside del virus adeno-asociado de serotipo 5 (aav5), capside y vector basado en la misma | |
| AR080229A1 (es) | Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23) | |
| BR112022000724A2 (pt) | Proteínas de capsídeo de aav modificado para tratamento de doença artrítica | |
| WO2021226267A3 (en) | Cross-species compatible adeno-associated virus compositions and methods of use thereof | |
| WO2023192463A3 (en) | Adeno-associated virus vectors for nucleic acid delivery to retinal cells | |
| CL2024002011A1 (es) | Virus del moquillo canino, composición; y uso. | |
| AR124651A1 (es) | Vectores de aav dirigidos a linfocitos t | |
| AR124736A1 (es) | EFECTO SINÉRGICO DE SMN1 Y miR-23a EN EL TRATAMIENTO DE LA ATROFIA MUSCULAR ESPINAL | |
| WO2023192459A3 (en) | Adeno-associated virus vectors | |
| PE20220429A1 (es) | Vectores viricos que codifican variantes del fviii recombinantes con mayor expresion para la genoterapia de la hemofilia a | |
| BR112021021792A2 (pt) | Composições úteis para tratamento de doença de pompe | |
| ECSP22092206A (es) | Ácido nucleico codón optimizado que codifica la proteina smn1 y su uso | |
| WO2025072688A3 (en) | Adeno-associated virus vectors for nucleic acid delivery to retinal cells | |
| BR112022003206A2 (pt) | Métodos para tratar doenças neovasculares oculares usando variantes de aav2 que codificam aflibercepte | |
| AR125143A1 (es) | Terapias génicas para la deficiencia de la 21-hidroxilasa | |
| AR128935A1 (es) | Vectores de virus adenoasociados para la entrega de ácido nucleico a las células retinianas | |
| AR128934A1 (es) | Vectores de virus adenoasociados para la entrega de ácido nucleico a través de las regiones retinianas | |
| AR126839A1 (es) | Proteína de la cápside vp1 modificada aislada del virus adeno-asociado de serotipo 9 (aav9), cápside y vector basado en esta |